Patient support programs / Artificial intelligence
Alec Batoian
I’ve built patient support programs for more than 100 brands at multinational pharmaceutical companies. Now I’m developing AI tools to help patients stay on treatment.
The work.
All projects ↗01Repeat purchases
1.4 → 2.83average 90-unit packs purchased per patient
We built and ran a pharmacy program to support repeat purchases. Average purchases were 1.4 large packs per patient in the first year and 2.83 at the final measurement, after three years.
Read the case02Access & services
Three patient needs. Three kinds of support.
We helped patients start treatment while waiting for public supply, buy medicine outside that supply, and use services around their care. Each needed its own rules and process.
Read the case03Devices
The meter is just the start.
We designed access to a glucose meter alongside pharmacy benefits for test strips. Eligibility checks, device delivery and repeat supplies were part of the same plan.
Read the case04Generic launch
A lab test gave a generic launch more to offer.
We paired a generic statin with a free lipid-profile test. It gave medical representatives a specific patient benefit to discuss with physicians, at a cost the program could support.
Read the case05Digital engagement
A treatment companion with a job to do.
We designed a messenger companion for registration, reminders and patient progress updates, alongside pharmacy benefits. Each message led to a specific action.
Read the case06Diagnostic access
Help patients reach the next diagnostic test.
We connected registration, referrals and testing providers in a staged diagnostic program, including travel and sample transport where needed.
Read the case
Lessons from practice.
Repeat purchases
The next purchase matters more than the first registration.
Registration shows who joined. Repeat purchases show who came back. If the goal is continued treatment, look beyond sign-ups.
Read the caseAccess & services
A service catalog is not a patient journey.
Patients need to know when a service can help and how to use it. Adding more services will not fix an unclear next step.
Read the caseDevices
Design for the refill, not just the device.
Getting a meter is one step. Buying test strips is a recurring need. Plan for both when designing the patient offer and its costs.
Read the caseGeneric launch
Give the offer a reason beyond price.
The lipid-profile test connected the offer to the patient’s treatment. It also gave medical representatives something specific to discuss with physicians.
Read the caseDigital engagement
Every prompt needs a job.
A reminder should help someone take the next step. Decide what that step is and what follows it before writing the message.
Read the caseDiagnostic access
Plan the steps between tests.
A patient may need a referral, a booking, transport or a follow-up. Decide who handles each step when planning the service and its budget.
Read the case
Program experience
Companies I’ve worked with.
Patient support projects for global and regional pharmaceutical companies.
- Abbott
- AbbVie
- Akrikhin
- AstraZeneca
- Belupo
- Biocodex
- GSK
- Ipsen
- Janssen / Johnson & Johnson
- KRKA
- Lundbeck
- Merz
- Novartis
- Novo Nordisk
- Ozon Pharma
- Pfizer
- Roche
- Sanofi
- Sentiss
- Solopharm
- Sun Pharma
- Teva
- Wörwag Pharma
Trade names & active ingredients
Brands I worked with.
Selected medicines from the programs I’ve worked on, grouped by therapeutic area. Brand names may differ by country.
Cardiology
- Atoris (atorvastatin)
- Binelol (nebivolol)
- Brilinta (ticagrelor)
- Clopidex (clopidogrel)
- Co-Dalneva (amlodipine + indapamide + perindopril)
- Co-Perineva (indapamide + perindopril)
- Coplavix (clopidogrel + acetylsalicylic acid)
- Dalneva (amlodipine + perindopril)
- Diovan (valsartan)
- Entresto (sacubitril + valsartan)
- Iruzid (lisinopril + hydrochlorothiazide)
- Omacor (omega-3 acids)
- Perineva (perindopril)
- Physiotens (moxonidine)
- Plavix (clopidogrel)
- Rosistark (rosuvastatin)
- Rosucard (rosuvastatin)
- Roxera (rosuvastatin)
- Telzap (telmisartan)
- Uptravi (selexipag)
- Zyllt (clopidogrel)
Oncology & hematology
- Afinitor (everolimus)
- Balversa (erdafitinib)
- Bosulif (bosutinib)
- Erleada (apalutamide)
- Exjade (deferasirox)
- Imbruvica (ibrutinib)
- Jakavi (ruxolitinib)
- Kisqali (ribociclib)
- Tyverb (lapatinib)
- Venclexta (venetoclax)
- Votrient (pazopanib)
Neuroscience
- Ajovy (fremanezumab)
- Akatinol Memantine (memantine)
- Ariprizol (aripiprazole)
- Dysport (botulinum toxin type A)
- Encetron-Solopharm (citicoline)
- Evrin (ethylmethylhydroxypyridine)
- Fevarin (fluvoxamine)
- Katena (gabapentin)
- Noben (idebenone)
- Serdolect (sertindole)
- Sumatriptan-Teva (sumatriptan)
- Tanakan (Ginkgo biloba extract)
Endocrinology
- Fiasp (insulin aspart)
- Fortedetrim (colecalciferol)
- Galvus Met (vildagliptin + metformin)
- Norditropin (somatropin)
- Ozempic (semaglutide)
- Ryzodeg (insulin degludec + insulin aspart)
- Saxenda (liraglutide)
Immunology
- Cosentyx (secukinumab)
- Rinvoq (upadacitinib)
- Skyrizi (risankizumab)
- Stelara (ustekinumab)
- Tremfya (guselkumab)
Ophthalmology
- Dorzolan (dorzolamide)
- Irifrin (phenylephrine)
- Midrimax (tropicamide + phenylephrine)
- Oftolik (povidone + polyvinyl alcohol)
- Prolatan (latanoprost)
- Travaksal (travoprost)
- Trilaktan (latanoprost)
Respiratory
- Seretide (salmeterol + fluticasone)
- Symbicort (budesonide + formoterol)
- Synagis (palivizumab)
- Ultibro (indacaterol + glycopyrronium bromide)
Rare diseases
- Kanuma (sebelipase alfa)
- Strensiq (asfotase alfa)
- Ultomiris (ravulizumab)
Other therapies
- Musculoskeletal healthArtogystan (chondroitin)
- Women's healthFemoston (estradiol + dydrogesterone)
- GastroenterologyGanaton (itopride)
- GastroenterologyPariet (rabeprazole)
- DermatologySotret (isotretinoin)